Position in UTHR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$15,502,869
+$1,080,269 QoQ
Shares Held
26,144
-11.7% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $35,025,551 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (44.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
148,191 | $19,522,682 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
26,144 | $15,502,869 |
All Filings in UTHR
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,502,869 | 26,144 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $14,422,600 | 29,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $30,937,698 | 73,800 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,022,240 | 118,400 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $31,474,367 | 102,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $23,499,144 | 66,600 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $21,895,185 | 61,100 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $11,181,105 | 35,100 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $7,626,704 | 33,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,806,095 | 35,500 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $7,769,928 | 34,400 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $7,792,475 | 35,300 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||